{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:52:43Z","timestamp":1780919563022,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003451","name":"Euskal Herriko Unibertsitatea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["25901"],"award-info":[{"award-number":["25901"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.livres.2025.10.002","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T15:23:59Z","timestamp":1761146639000},"page":"338-350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic potential of miRNA-26a-encapsulated nanoparticles against hepatocellular carcinoma in a murine model"],"prefix":"10.1016","volume":"9","author":[{"given":"Marwa","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Fern\u00e1ndez-Pi\u00f1eiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iker","family":"Badiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elzallat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Aboushousha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1551-4309","authenticated-orcid":false,"given":"Ehab","family":"Hafiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"El-Ahwany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2025.10.002_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.livres.2025.10.002_bib2","doi-asserted-by":"crossref","unstructured":"Hassan M, El-Maadawy WH, Fahim SA, Youssef SM, Badran OM, Balata M. Integrating \u200eCTLA-4 genetics and soluble isoforms for the stratification of HCV-related hepatocellular \u200ecarcinoma risk and aggressiveness. Int J Mol Sci. 2025;26:11067. https:\/\/doi.org\/10.3390\/IJMS262211067.","DOI":"10.3390\/ijms262211067"},{"key":"10.1016\/j.livres.2025.10.002_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.livres.2023.11.004","article-title":"Hepatocellular carcinoma recurrence: predictors and management","volume":"7","author":"Abdelhamed","year":"2023","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2025.10.002_bib4","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.26452\/ijrps.v10i4.1574","article-title":"Effect of interferon-beta (IFN-\u03b2) on tumor suppressor and apoptotic markers in hepatocellular carcinoma cell line","volume":"10","author":"Okasha","year":"2019","journal-title":"Int J Res Pharm Sci"},{"key":"10.1016\/j.livres.2025.10.002_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117228","article-title":"Innovative model of surface-enhanced Raman spectroscopy for exosomes identification: an approach for the diagnosis of hepatocellular carcinoma","volume":"540","author":"Elkady","year":"2023","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.livres.2025.10.002_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ncrna.2022.12.006","article-title":"Circulating liver cancer stem cells and their stemness-associated microRNAs as diagnostic and prognostic biomarkers for viral hepatitis-induced liver cirrhosis and hepatocellular carcinoma","volume":"8","author":"Hassan","year":"2023","journal-title":"Non-coding RNA Res"},{"key":"10.1016\/j.livres.2025.10.002_bib7","article-title":"New frontiers in liver resection for hepatocellular carcinoma","volume":"2","author":"Allaire","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.livres.2025.10.002_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.livres.2025.10.002_bib9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.livres.2025.10.002_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"Bruix","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.livres.2025.10.002_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-021-00350-4","article-title":"Recent advances in systemic therapy for hepatocellular carcinoma","volume":"10","author":"Zhang","year":"2022","journal-title":"Biomark Res"},{"key":"10.1016\/j.livres.2025.10.002_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.livres.2023.01.001","article-title":"Novel insights into the impact of liver inflammatory responses on primary liver cancer development","volume":"7","author":"Ait-Ahmed","year":"2023","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2025.10.002_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3390\/gidisord3040022","article-title":"MicroRNAs as diagnostic tools in hepatocellular carcinoma","volume":"3","author":"Evangelista","year":"2021","journal-title":"Gastrointest Disord"},{"key":"10.1016\/j.livres.2025.10.002_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-018-0587-8","article-title":"The role and mechanisms of action of microRNAs in cancer drug resistance","volume":"11","author":"Si","year":"2019","journal-title":"Clin Epigenet"},{"key":"10.1016\/j.livres.2025.10.002_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2019.10.007","article-title":"MicroRNA delivery through nanoparticles","volume":"313","author":"Lee","year":"2019","journal-title":"J Contr Release"},{"key":"10.1016\/j.livres.2025.10.002_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jare.2020.08.012","article-title":"Therapeutic advances of miRNAs: a preclinical and clinical update","volume":"28","author":"Chakraborty","year":"2021","journal-title":"J Adv Res"},{"key":"10.1016\/j.livres.2025.10.002_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-020-1166-6","article-title":"MiR-26a\/miR-26b represses tongue squamous cell carcinoma progression by targeting PAK1","volume":"20","author":"Wei","year":"2020","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.livres.2025.10.002_bib18","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2147\/OTT.S241199","article-title":"miR-26a-5p inhibit gastric cancer cell proliferation and invasion through mediated Wnt5a","volume":"13","author":"Li","year":"2020","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.livres.2025.10.002_bib19","first-page":"1","article-title":"MicroRNA-26a represses pancreatic cancer cell malignant behaviors by targeting E2F7","volume":"12","author":"Wang","year":"2021","journal-title":"Discov Oncol"},{"key":"10.1016\/j.livres.2025.10.002_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2021.12628","article-title":"MicroRNA-26a inhibits cell proliferation and invasion by targeting FAM98A in breast cancer","volume":"21","author":"Liu","year":"2021","journal-title":"Oncol Lett"},{"key":"10.1016\/j.livres.2025.10.002_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay3051","article-title":"MiR-26a regulates extracellular vesicle secretion from prostate cancer cells via targeting SHC4, PFDN4, and CHORDC1","volume":"6","author":"Urabe","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.livres.2025.10.002_bib22","first-page":"3523","article-title":"MiRNA-26a-5p and miR-26b-5p inhibit the proliferation of bladder cancer cells by regulating PDCD10","volume":"40","author":"Wu","year":"2018","journal-title":"Oncol Rep"},{"key":"10.1016\/j.livres.2025.10.002_bib23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.cell.2009.04.021","article-title":"Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model","volume":"137","author":"Kota","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.livres.2025.10.002_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-019-0802-5","article-title":"Cell migration and proliferation are regulated by miR-26a in colorectal cancer via the PTEN-AKT axis","volume":"19","author":"Coronel-Hern\u00e1ndez","year":"2019","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.livres.2025.10.002_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.738219","article-title":"Delivery of miR-26a using an exosomes-based nanosystem inhibited proliferation of hepatocellular carcinoma","volume":"8","author":"Mahati","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.livres.2025.10.002_bib26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ijc.31343","article-title":"Targeting liver sinusoidal endothelial cells with miR-20a-loaded nanoparticles reduces murine colon cancer metastasis to the liver","volume":"143","author":"Marquez","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.livres.2025.10.002_bib27","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1139\/o59-074","article-title":"Evaluation of protein in foods. I. A method for the determination of protein efficiency ratios","volume":"37","author":"Chapman","year":"1959","journal-title":"Can J Biochem Physiol"},{"key":"10.1016\/j.livres.2025.10.002_bib28","series-title":"Carleton's Histological Techniqu. 5th Edition. New York (NY): Oxford University Press","author":"Drury","year":"1980"},{"key":"10.1016\/j.livres.2025.10.002_bib29","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.3390\/cancers13112680","article-title":"Microrna therapeutics in cancer: current advances and challenges","volume":"13","author":"Sayed","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.livres.2025.10.002_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.461","article-title":"MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy","volume":"8","author":"Jin","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.livres.2025.10.002_bib31","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/jphp.13351","article-title":"Recent trends in targeting miRNAs for cancer therapy","volume":"72","author":"Shah","year":"2020","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.livres.2025.10.002_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e15288","article-title":"Nanoconjugated long non-coding RNA MEG3 as a new therapeutic approach for hepatocellular carcinoma","volume":"9","author":"Elzallat","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.livres.2025.10.002_bib33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ncrna.2022.11.005","article-title":"MicroRNA-122 mimic\/microRNA-221 inhibitor combination as a novel therapeutic tool against hepatocellular carcinoma","volume":"8","author":"Hassan","year":"2023","journal-title":"Non-coding RNA Res"},{"key":"10.1016\/j.livres.2025.10.002_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/mps4010010","article-title":"Recent advances in miRNA delivery systems","volume":"4","author":"Dasgupta","year":"2021","journal-title":"Methods Protoc"},{"key":"10.1016\/j.livres.2025.10.002_bib35","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.1038\/sj.onc.1210564","article-title":"Specific microRNAs are downregulated in human thyroid anaplastic carcinomas","volume":"26","author":"Visone","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.livres.2025.10.002_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/4c8d2e73-67b1-473d-ae8e-4f847a5f7ef8","article-title":"MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1","volume":"8","author":"Gao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.livres.2025.10.002_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072662","article-title":"MiR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer","volume":"8","author":"Deng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.livres.2025.10.002_bib38","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.bbadis.2012.07.019","article-title":"MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN","volume":"1822","author":"Liu","year":"2012","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.livres.2025.10.002_bib39","article-title":"MiR-26a promotes ovarian cancer proliferation and tumorigenesis","volume":"9","author":"Shen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.livres.2025.10.002_bib40","first-page":"1","article-title":"Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma","volume":"38","author":"Wang","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.livres.2025.10.002_bib41","doi-asserted-by":"crossref","first-page":"188","DOI":"10.21037\/hbsn-23-653","article-title":"Hepatocellular carcinoma with macrovascular invasion: need a personalized medicine for this complicated event","volume":"13","author":"Hwang","year":"2024","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.livres.2025.10.002_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.20892\/j.issn.2095-3941.2022.0449","article-title":"Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies","volume":"20","author":"Yao","year":"2023","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.livres.2025.10.002_bib43","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1158\/1078-0432.CCR-18-1254","article-title":"The role of angiogenesis in hepatocellular carcinoma","volume":"25","author":"Morse","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.livres.2025.10.002_bib44","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1038\/s41598-024-58708-1","article-title":"CircSNX6 promotes proliferation, metastasis, and angiogenesis in hepatocellular carcinoma via miR-383-5p\/VEGFA signaling pathway","volume":"14","author":"Tian","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.livres.2025.10.002_bib45","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3389\/fphar.2018.01509","article-title":"MiR-26 induces apoptosis and inhibits autophagy in non-small cell lung cancer cells by suppressing TGF-\u03b21-JNK signaling pathway","volume":"9","author":"He","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.livres.2025.10.002_bib46","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1159\/000526666","article-title":"Upregulation of miRNA-26a enhances the apoptosis of cerebral neurons by targeting EphA2 and inhibiting the MAPK pathway","volume":"44","author":"Chi","year":"2023","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.livres.2025.10.002_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/genes11111336","article-title":"DNMTs and impact of CpG content, transcription factors, consensus motifs, lncRNAs, and histone marks on DNA methylation","volume":"11","author":"Loaeza-Loaeza","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.livres.2025.10.002_bib48","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/carcin\/bgaa088","article-title":"DNMT1 and DNMT3B regulate tumorigenicity of human prostate cancer cells by controlling RAD9 expression through targeted methylation","volume":"42","author":"Zhu","year":"2021","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.livres.2025.10.002_bib49","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcab045","article-title":"Misregulation of the expression and activity of DNA methyltransferases in cancer","volume":"3","author":"Mensah","year":"2021","journal-title":"NAR Cancer"},{"key":"10.1016\/j.livres.2025.10.002_bib50","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.3892\/or.2017.5579","article-title":"MicroRNA-26a inhibits proliferation and metastasis of human hepatocellular carcinoma by regulating DNMT3B-MEG3 axis","volume":"37","author":"Li","year":"2017","journal-title":"Oncol Rep"},{"key":"10.1016\/j.livres.2025.10.002_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2022.198928","article-title":"Association of Sat-a and Alu methylation status with HCV-induced chronic liver disease and hepatocellular carcinoma","volume":"321","author":"El-Ahwany","year":"2022","journal-title":"Virus Res"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568425000650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568425000650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:13:14Z","timestamp":1778897594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542568425000650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2542568425000650"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2025.10.002","relation":{},"ISSN":["2542-5684"],"issn-type":[{"value":"2542-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of miRNA-26a-encapsulated nanoparticles against hepatocellular carcinoma in a murine model","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2025.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd\u00e9","name":"copyright","label":"Copyright"}]}}